Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-24 to 2023-05-25
Current total value of award: $8478.82
Description: 4561037212!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML